NetworkNewsBreaks

TuesdayJan 05, 2021 11:04 am

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Successful Fuel4Thought(TM) Study, Substantial Opportunity for Proven, Market-Disruptive Remedy

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary, Ultimate Brain Nutrients(TM) (“UBN”) has successfully completed a pilot study for its proprietary Fuel4Thought(TM) (F4T(TM)) formulation to help with migraines. It is an exciting development for Grey Cloak as it looks to embolden its revenue opportunities, providing substantial potential reach for a proven, market-disruptive remedy. According to GRCK president Duke Pitts, nearly 40 million people suffer from some form of migraines in the United States…

Continue Reading

TuesdayJan 05, 2021 10:39 am

NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters into Agreement with Fortune 500 Subsidiary to Provide Digital Therapeutics Solution

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has been selected by a subsidiary of a U.S.-based Fortune 500 technology and engineering company to provide its digital therapeutics solution to eligible employees. DarioHealth’s partnership with Vitality Group made this agreement possible, which is DarioHealth’s first client in the self-insured employer market. One of the largest wellness companies in the world, Vitality Group blends industry-leading smart tech, data, incentives and behavioral science to inspire healthy changes in individuals and their organizations; an estimated 20 million people in 26 markets engage in the Vitality program. Under the announced agreement, members…

Continue Reading

TuesdayJan 05, 2021 10:05 am

NetworkNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in LifeSci Partners Corporate Access Event

AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, will be participating in the 10th annual LifeSci Partners Corporate Access Event. As part of the company’s participation, AzurRx president and CEO James Sapirstein will present a summary of the company’s business and clinical-development programs to any interested parties. His presentation will also include expected 2021 highlights. In addition, Sapirstein will participate in virtual one-on-one meetings with registered investors and pharmaceutical companies. The multiday event is scheduled for Jan. 6–8 and 11–14, 2021. To register for the event, visit https://nnw.fm/DlFTY To view the full press release, visit…

Continue Reading

MondayJan 04, 2021 3:55 pm

NetworkNewsBreaks – HempFusion Wellness Inc. Eyes IPO Completion, Scaling of Domestic, International Operations and Accelerated Growth

HempFusion Wellness, a leader in the health and wellness cannabidiol (“CBD”) industry, recently announced filing of its final prospectus with the securities regulatory authorities in each of Canada’s provinces, with exception to Québec. According to the update, the final prospectus was filed in connection with HempFusion’s previously-announced initial public offering of up to 7,000,000 of its common shares and up to 10,000,000 units of the company at a price of US$1.00 per offered share and per unit for gross proceeds of up to US$17,000,000. Subject to customary conditions, the offering is expected to close on or around Jan. 6, 2021.…

Continue Reading

MondayJan 04, 2021 2:50 pm

NetworkNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Commences Trading on the OTCQB(R) Venture Market

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) recently announced that, effective Dec. 22, 2020, its common shares commenced trading on the OTCQB(R) Venture Market in the United States under the symbol "PLTXF." According to the update, PlantX continues to advance its plans to open its first brick-and-mortar locations in San Diego, California, and Squamish, British Columbia, with intentions of future franchising across North America. The company will also continue to expand its e-commerce capabilities around the world with new and exciting partnerships, acquisitions and verticals in the plant-based industry. "The addition of another trading platform will continue to increase…

Continue Reading

MondayJan 04, 2021 2:35 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Shares Objectives for Berubicin Phase 2 Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, recently hosted a webinar to discuss the clinical design for its upcoming Phase 2 trial. The trial will study its lead drug candidate, Berubicin, for the treatment of glioblastoma multiforme (“GBM”), an aggressive form of brain cancer currently considered incurable. Berubicin is an anthracycline that has demonstrated significant potential to effectively cross the blood-brain barrier and target central nervous system malignancies. The company’s Phase 2 trial will recruit 243 patients for side-by-side, real-time analysis…

Continue Reading

MondayJan 04, 2021 2:26 pm

NetworkNewsBreaks – Knightscope Inc. Deploys K5 ASR Solution for Phoenix-Based Shopping Center

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its entry into another contract in Arizona. According to NRF, organized retail crime (“ORC”) costs the retail industry approximately $30 billion each year, and preparation is a key factor in prevention. A Phoenix, Arizona-based shopping center has elected to take the proactive approach of hiring Knightscope’s K5 ASR to help protect its property, tenants and patrons. To view the full update, visit https://nnw.fm/0YXg9 About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots (“ASRs”) that…

Continue Reading

MondayJan 04, 2021 2:02 pm

NetworkNewsBreaks – Retractable Technologies Inc. (NYSE: RVP) Named ‘2020’s Stock of the Year’ by The Bowser Report

Retractable (NYSE: RVP), a manufacturer and marketer of safety syringes and other innovative medical products for the health care industry, was recognized as the “Stock of the Year” for 2020 by The Bowser Report LLC. The report reads, “Unlike last year’s top pick [Repro Med Systems Inc. (NASDAQ: KRMD)], Retractable Technologies is a recent addition to the newsletter, named Company of the Month in January 2020. At the time, RVP was trading at $1.48. Just a couple of months after recommendation, the world and financial markets were shocked by the COVID-19 pandemic, which forced lockdowns, quarantines and stay-at-home orders. While…

Continue Reading

MondayJan 04, 2021 1:34 pm

NetworkNewsBreaks – PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Announces CFO Appointment of Corporate Finance Veteran

PowerBand Solutions (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), an innovative automotive fintech leader providing digital and virtual platform solutions, today announced the appointment of Shibu Abraham CPA as its chief financial officer. Abraham has more than 25 years of accounting and financial management experience for various private and publicly traded companies listed on stock exchanges in both Canada and the United States. "Shibu has the skill set we require for public accounting coupled with his experience in guiding the financial affairs of small to midcap companies," said Kelly Jennings, CEO of PowerBand. "We are very pleased that Mr. Abraham has…

Continue Reading

MondayJan 04, 2021 1:29 pm

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Announces Strategic Board Appointment, Continued Drive of Integrated Data-Driven Solutions

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced the addition of Philip Kan to its board of directors, effective Jan. 1, 2021. Per the update, Kan will chair iClick’s Nominating and Corporate Governance Committee. "The addition of Philip to the board will help bring additional guidance and leadership for iClick at the stage of our continued growth," said Jian "T.J." Tang, iClick's CEO and co-founder. "Philip brings tremendous business experience, much of it in management and leadership roles in the financial sector in Hong Kong and mainland China that…

Continue Reading